Status:
RECRUITING
Augmented Bladder Tumor Detection Using Real Time Based Artificial Intelligence
Lead Sponsor:
Centre Hospitalier Universitaire, Amiens
Conditions:
Bladder Cancer
Cystoscopy
Eligibility:
All Genders
18+ years
Brief Summary
Today the standard for the diagnosis and monitoring of bladder tumors is bladder endoscopy. The performance of this exam is not perfect. With this work, based on artificial intelligence, the investiga...
Eligibility Criteria
Inclusion
- unifocal primary or recurrent suspected bladder cancer with tumor size less or equal than 3 cm
- multifocal primary or recurrent suspected bladder cancer less or equal than 5 lesions and with tumor size less or equal than 3 cm.
Exclusion
- Evidence of more than 5 tumors or more than 3 cm
- computed tomography/cystoscopy suspect of muscle-invasive bladder cancer (cT2 or higher)
- computed tomography/magnetic resonance evidence of distant metastases (lymphatic or organic)
- Exclusion criteria will include gross hematuria and bacillus Calmette-Guerin (BCG) treatment or chemotherapy within 3 months of inclusion
- An exception will be made if patients had received only a single course of chemotherapy immediately following TUR
- Patients objecting to the use of their data in the context of research.
Key Trial Info
Start Date :
May 13 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT05415631
Start Date
May 13 2022
End Date
May 1 2029
Last Update
July 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amiens University Hospital
Amiens, France, 80054